Navigation Links
Kendle Launches New Global Biostatistics Infrastructure

CINCINNATI, March 9 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the implementation of a new biostatistics infrastructure that will significantly enhance the analysis and delivery of quality clinical trial data for customers. The centralized SAS®-based platform provides a virtual environment allowing for simultaneous access and analysis of clinical trial data by Kendle's global Biostatistics and Scientific Programming teams from anywhere in the world, creating significant time savings and further enhancing data security. The launch of the new system will be seamless to customers.

"With this new environment data will be processed at the server level much faster than ever before, greatly improving the productivity of our teams around the world and expediting the delivery of quality data to our customers," said John A. Whitaker, Ph.D., Vice President, Biostatistics and Statistical Programming.  "This investment allows Kendle to provide a more globally integrated solution to meet our customers' needs anywhere, any time."

In addition to improved efficiency, quality and security, the centralized platform also positions Kendle to better leverage its growing operations in India.  Other benefits of the new infrastructure implementation include improved network performance and bandwidth availability; reduced licensing requirements; and simplification of the testing, production and recovery environments.

Kendle's Biostatistics and Scientific Programming team is comprised of a worldwide network of experts utilizing globally consistent processes to maximize operating efficiencies and ensure delivery of the highest quality data analysis and reporting to our customers.  The team specializes in the planning and execution of meaningful analyses of even the most complex clinical trials.  Kendle is equipped to provide actionable data as either a functional service or full service provider, and is currently involved in statistical services worldwide.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at

Forward-Looking Statements

Certain statements and information contained in this press release may be deemed to be forward-looking statements under federal securities laws and the provisions of the Private Securities Litigation Reform Act of 1995 and Kendle intends that such forward-looking statements be subject to the safe-harbor created thereby. All such forward-looking statements, including the statements contained herein regarding anticipated trends from Kendle's implementation of the SAS® server-based solution are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include those risks as detailed from time to time in Kendle's Annual Report on Form 10-K as well as periodic reports filed with the SEC.   All information in this press release is current as of March 9, 2010. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

SOURCE Kendle International Inc.

Back to top



SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
2. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
3. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
4. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
5. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
6. Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
7. Feintuch Communications Launches Integrated PR and IR Practice for Healthcare and Life Sciences Organizations
8. Pioneer(R) Surgical Technology, Inc. Launches Contact(R) Anterior Lumbar Plate March 1
9. Hexaware Launches HPower10 for the Healthcare Industry
10. TechniScan Launches 3-D Breast Ultrasound Clinical Study in Freiburg University
11. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
Post Your Comments:
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):